chr1-161984911-C-T
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM2PP3_Strong
The NM_015441.3(OLFML2B):c.1544G>A(p.Gly515Glu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000993 in 1,611,490 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_015441.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
OLFML2B | NM_015441.3 | c.1544G>A | p.Gly515Glu | missense_variant | 7/8 | ENST00000294794.8 | |
OLFML2B | NM_001347700.2 | c.1550G>A | p.Gly517Glu | missense_variant | 7/8 | ||
OLFML2B | NM_001297713.2 | c.1547G>A | p.Gly516Glu | missense_variant | 7/8 | ||
OLFML2B | XM_011509398.3 | c.824G>A | p.Gly275Glu | missense_variant | 4/5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
OLFML2B | ENST00000294794.8 | c.1544G>A | p.Gly515Glu | missense_variant | 7/8 | 1 | NM_015441.3 | P3 | |
OLFML2B | ENST00000367940.2 | c.1547G>A | p.Gly516Glu | missense_variant | 7/8 | 2 | A2 | ||
OLFML2B | ENST00000367938.1 | c.-8G>A | 5_prime_UTR_variant | 1/2 | 2 |
Frequencies
GnomAD3 genomes AF: 0.00000668 AC: 1AN: 149638Hom.: 0 Cov.: 27
GnomAD4 exome AF: 0.0000103 AC: 15AN: 1461852Hom.: 0 Cov.: 31 AF XY: 0.0000138 AC XY: 10AN XY: 727230
GnomAD4 genome AF: 0.00000668 AC: 1AN: 149638Hom.: 0 Cov.: 27 AF XY: 0.0000137 AC XY: 1AN XY: 72832
ClinVar
Submissions by phenotype
not provided Pathogenic:1
Likely pathogenic, no assertion criteria provided | research | Medizinische Klinik 1/ Institut für Bioinformatik, Universitätsklinikum Großhadern, München/ Helmholtz Zentrum München | Aug 01, 2015 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 14, 2023 | The c.1544G>A (p.G515E) alteration is located in exon 7 (coding exon 7) of the OLFML2B gene. This alteration results from a G to A substitution at nucleotide position 1544, causing the glycine (G) at amino acid position 515 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at